Patrick A. Mayes - 16 Jan 2026 Form 4 Insider Report for INCYTE CORP (INCY)

Role
EVP & Chief Scientific Officer
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Issuer symbol
INCY
Transactions as of
16 Jan 2026
Net transactions value
$0
Form type
4
Filing time
21 Jan 2026, 16:04:27 UTC
Previous filing
12 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mayes Patrick A EVP & Chief Scientific Officer 1801 AUGUSTINE CUT-OFF, WILMINGTON /s/ Elizabeth Feeney, Attorney-In-Fact 21 Jan 2026 0002079962

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INCY Employee Stock Option (right to buy) Award $0 +4,218 $0.000000 4,218 16 Jan 2026 Common Stock 4,218 $106.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Beginning January 16, 2026, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2026 and the remainder vesting monthly over three years.